CARGO Therapeutics
CRGX
CRGX was delisted on the 18th of August, 2025.
73 hedge funds and large institutions have $716M invested in CARGO Therapeutics in 2024 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 31 increasing their positions, 16 reducing their positions, and 9 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
100% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 9
94% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 16
12% more funds holding
Funds holding: 65 → 73 (+8)
2.68% more ownership
Funds ownership: 92.45% → 95.13% (+2.7%)
12% less capital invested
Capital invested by funds: $812M → $716M (-$95.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$27.9M |
| 2 |
YF
Yu Fan
|
+$17.3M |
| 3 |
SVCM
Saturn V Capital Management
Austin,
Texas
|
+$16.3M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$13.2M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$10.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PBA
Paradigm Biocapital Advisors
New York
|
-$3.3M |
| 2 |
SC
Stempoint Capital
New York
|
-$1.14M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$1.12M |
| 4 |
Millennium Management
New York
|
-$644K |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$589K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AIG
76
American International Group
New York
| – | -$237K | -10,597 | Closed |
|
77
Balyasny Asset Management
Chicago,
Illinois
| – | -$234K | -10,464 | Closed |
|
|
SO
78
STRS Ohio
Columbus,
Ohio
| – | -$84K | -3,800 | Closed |
|
|
MLICM
79
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$25.9K | -1,162 | Closed |
|
|
GI
80
GAMMA Investing
Foster City,
California
| – | -$179 | -8 | Closed |
|
81
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | +$190 | +10 | New |
|
82
Lazard Asset Management
New York
| – | +$608 | +32 | New |
|
CRGX Hedge Fund Activity: Q2 2024 in Review
73 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in CARGO Therapeutics (CRGX) for Q2 2024, worth a combined $716M — down 12% from $812M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new CRGX positions and 9 closed out — a net gain of 9 holders — while 31 added to existing stakes and 16 trimmed.
The largest buyer was EcoR1 Capital, opening a new position worth an estimated $27.9M. The largest seller was Paradigm Biocapital Advisors, exiting entirely with an estimated $3.3M sold.
- 73 institutional investors held CARGO Therapeutics (CRGX) as of Q2 2024, up from 65 in Q1 2024.
- Funds reported $716M of CARGO Therapeutics stock for Q2 2024, down 12% quarter-over-quarter.
- 18 funds opened new CARGO Therapeutics positions in Q2 2024 and 9 closed out, a net change of +9 holders.
- The largest CARGO Therapeutics buyer in Q2 2024 was EcoR1 Capital, an estimated $27.9M added.
- The largest CARGO Therapeutics seller in Q2 2024 was Paradigm Biocapital Advisors, an estimated $3.3M sold.
Based on aggregated 13F filings for Q2 2024.